NEW YORK (GenomeWeb) – A seven-gene test for breast cancer risk could be cost-effective in improving life expectancy among women with a family history of disease, according to a new study from Quest Diagnostic researchers.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.